Tag - medicine-4

 
Menu
Search
 
July 28, 2024
 

Today's print edition

Home Delivery
Subscribe for more access

MEDICINE 4

Japan Times
COMMENTARY / World
Nov 20, 2020
What COVID-19 is costing women?
The pandemic has compounded a longstanding problem for women around the world: large and persistent barriers to participating in the economy and public life on an equal basis with men.
Japan Times
WORLD / Science & Health
Nov 20, 2020
WHO advises doctors not to use Gilead’s remdesivir for COVID-19
The recommendation is a blow to Gilead's drug, which was one of the first thought to offer a meaningful benefit in treatment of coronavirus patients.
Japan Times
COMMENTARY / World
Nov 19, 2020
COVID-19 mutated. Can vaccines keep up?
So far, scientists have found only one mutation that improves the survival ability of the virus. The more transmissible strain is referred to as G614.
Japan Times
WORLD / Science & Health
Nov 19, 2020
Can first vaccines bring herd immunity? Experts have doubts.
Figuring out what's needed to achieve herd immunity with COVID-19 vaccines involves a range of factors, several of which are unknown.
Japan Times
WORLD / Science & Health
Nov 19, 2020
Pfizer-BioNTech coronavirus vaccine deliveries could start 'before Christmas'
Final trial results showed the vaccine had a 95% success rate and no serious side effects, the drugmakers said.
Japan Times
COMMENTARY / Japan
Nov 18, 2020
Can Japan bridge the vaccine divide?
Japan too has been developing its own drug, Avigan, against COVID-19. Yet the drug being developed by Fujifilm is not a vaccine but rather a treatment for coronavirus symptoms.
Japan Times
ASIA PACIFIC / Science & Health
Nov 18, 2020
China takes risk in rushing to use unproven coronavirus vaccines
China has made its unproven candidates widely available to demonstrate their safety and effectiveness to a country that has long been skeptical of vaccines.
Japan Times
ASIA PACIFIC / Science & Health
Nov 18, 2020
Sinovac's COVID-19 vaccine induces quick immune response, study finds
Sinovac Biotech's experimental COVID-19 vaccine CoronaVac triggered a quick immune response but the level of antibodies produced was lower than in people who had recovered from the disease, preliminary trial results showed on Wednesday.
Japan Times
WORLD / Science & Health
Nov 18, 2020
Pfizer reaches safety milestone for COVID-19 vaccine, CEO says
Pfizer Inc. Chief Executive Officer Albert Bourla said that a key safety milestone had been reached in the study of its COVID-19 vaccine, and the drugmaker is now preparing to seek an emergency-use authorization from U.S. regulators.
Japan Times
WORLD / Science & Health / FOCUS
Nov 18, 2020
How Pfizer and BioNTech sprinted ahead in extraordinary race for a COVID-19 vaccine
Researchers were asked to tackle something that had never been done before: design a vaccine to stop a pandemic in its tracks in less than a year.
Japan Times
WORLD / Science & Health
Nov 17, 2020
Moderna’s COVID-19 vaccine: What you need to know
Coming a week after similar news from Pfizer and BioNTech, Moderna's announcement offered more hope that there's going to be a way out of the pandemic.
Japan Times
WORLD / Science & Health
Nov 17, 2020
WHO warns against COVID-19 complacency after Moderna vaccine news
'Right now we are extremely concerned by the surge in cases we are seeing in some countries,' WHO director-general Tedros Adhanom Ghebreyesus told a news briefing.
Japan Times
WORLD / Science & Health
Nov 17, 2020
How the Moderna and Pfizer coronavirus vaccines stack up
The encouraging late-stage trial results from Pfizer Inc. and Moderna Inc. set a high bar for rivals that are expected to follow soon with their own pivotal reports.
Japan Times
WORLD
Nov 16, 2020
Drugmaker Moderna says COVID-19 vaccine shows nearly 95% protection
A key advantage of Moderna's vaccine is that it does not need ultracold storage like Pfizer's, making it easier to distribute.
Japan Times
COMMENTARY / World
Nov 16, 2020
A vaccine won't derail the easy money train
Don't get carried away by the good news on vaccine development. Central banks are miles from the exit ramp for the tremendous stimulus they've pumped into the economy.
Japan Times
WORLD
Nov 16, 2020
U.S. doctors are calling it quits under stress of the pandemic
Thousands of medical practices have closed during the pandemic, according to a July survey of 3,500 doctors by the Physicians Foundation, a nonprofit group.
Japan Times
COMMENTARY / World
Nov 15, 2020
Here’s to the immigrant heroes behind the BioNTech vaccine
Their journey as Turkish Germans cannot have been easy. Discrimination, overt or subtle, is rife in German society.
Japan Times
JAPAN / Media / MEDIA MIX
Nov 14, 2020
Subsidizing fertility treatment leaves Japanese gynecologists in a bind
Fertility treatments are not covered by national health insurance because, in most cases, infertility is not defined as an ailment.
Japan Times
COMMENTARY / World
Nov 13, 2020
What happens to the other COVID-19 vaccines now?
If the vaccine created by Pfizer and partner BioNTech fails to live up to its promise, will any slower but better competitors have a chance?
Japan Times
ASIA PACIFIC
Nov 13, 2020
China under pressure to reveal vaccine data after Pfizer success
While Beijing has hailed the progress on its own own COVID-19 vaccines, it has so far yet to back this up with evidence.
Ryuju Nagayama falls in controversial ruling in Paris, later earns bronze
Ryuju Nagayama reacts after his quarterfinal bout against Spain's Francisco Garrigos at the Paris Olympics on Saturday.
Dominant Natsumi Tsunoda delivers Japan's first gold medal at Paris Olympics
Gold medalist Natsumi Tsunoda celebrates on the podium after she won the women's under 48-kg division at the Paris Olympics on Saturday.
Japan's population continues to fall even as foreign resident count rises
The number of residents in Tokyo as of Jan. 1 rose by 0.03% from a year before, data shows, marking a year-on-year increase for the first time in three years, while the country's other 46 prefectures saw their populations continue to decline.
Ahead of the Olympics, Japan is still talking about the gymnast who won't be there
Japan's Shoko Miyata withdrew from the gymnastics team herself over her drinking and smoking, although it had already appeared as though the association was prepared to send her home from the team’s training camp in Monaco.
Yen melt-up nudges Japanese stocks into correction territory
Japanese stocks are down 10% from their July peak as the yen strengthens.
When did summer in Japan stop being fun?
Summer in Japan is now consistently brutal enough to drive you indoors and keep you there until autumn.
The Japanese Olympians looking to shine in Paris
Rim Nakamura, who is attempting to win Japan's first Olympic gold medal in cycling, will be one of the top Japanese athletes to watch at the Paris Games.
Japan’s minimum wage set for record ¥50 hike in major boost
Demonstrators rally to demand a big hike in minimum wages in Tokyo last week.
Japan loses top spot on strongest passport list to Singapore
Japan had the strongest passport for six years running from 2018, before being dethroned by Singapore on the 2024 list.
Why Japan's mysterious stash of classified funds escapes scrutiny
Prime Minister Fumio Kishida and Chief Cabinet Secretary Yoshimasa Hayashi (right) during a meeting in Tokyo on Tuesday.

Podcast

One of the many entrances to the Kabukicho neighborhood in Tokyo’s Shinjuku Ward.
Kabukicho: Tokyo’s ‘stadium of desire’

Longform

Traditional folk rituals like Mizudome-no-mai (dance to stop the rain) provide a sense of agency to a population that feels largely powerless in the face of the climate crisis.
As climate extremes intensify, Japan embraces ancient weather rituals
By Alex K.T. Martin

SUSTAINABLE JAPAN

mission sustainability vol.11 : Sekisui House Ltd.World’s top homebuilder acts on its responsibility
mission sustainability vol.11 : Sekisui House Ltd.World’s top homebuilder acts on its responsibility

SPECIAL SUPPLEMENTS note

Read more

SUPPLEMENTS BINDER